We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MR Prostate Coil Customizes Treatment Planning

By HospiMedica staff writers
Posted on 17 Aug 2006
A new prostate coil is designed to produce very accurate magnetic resonance (MR) images for targeted prostate cancer treatment.

To enable personalized treatment planning that may reduce considerable side effects of prostate cancer treatment, Medrad (Indianola, PA, USA) and GE Healthcare (Chalfont St. More...
Giles, UK) announce the availability of the first endorectal coil for 3.0T MR prostate imaging. The Medrad 3.0T Prostate eCoil is available for GE Signa HDx 3.0T MR scanners.

Patients diagnosed with prostate cancer frequently undergo either a radical prostatectomy, or radiation treatment over large portions of the prostate to combat the cancer. The after-effects on the patient can include impotence, urinary incontinence, and bleeding. Medrad created the 3.0T Prostate eCoil to produce very accurate diagnostic images of the prostate that may enable early diagnosis and staging of prostate cancer. The coil can also be used to plan radiation therapy in a way that helps clinicians localize treatment to only the affected part of the gland. By giving clinicians more accurate images for use in planning and delivering targeted treatment, the eCoil may help them customize the patient's treatment.

The eCoil balloon conforms to the size and shape of the prostate for consistent contact between the gland and the signal-amplifying elements of the coil. The result is small field-of-view (FOV) and high spatial resolution, sensitivity, and specificity that provide clearer images of the prostate.

John Kurhanewicz, Ph.D., director of the Prostate Imaging Group and Biomedical NMR Lab and professor of radiology and pharmaceutical chemistry at the University of California, San Francisco (UCSF; USA) School of Medicine, has noted similar results on a GE scanner. "The increased spectral dispersion obtainable at 3.0T allows for better quantification of metabolites, notably the elevation of choline resonance, which has emerged as the most specific marker for prostate cancer,” said Dr. Kurhanewicz.

The Prostate eCoil is also available for 1.5T magnet strength environments and is one of Medrad's Leading Image MR Coil products.



Related Links:
Medrad
GE Healthcare

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.